Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.

Connecticut's strategic venture capital arm, today announced that it invested approximately $7.8 million in 17 companies and venture funds during the second quarter of its fiscal year, ending December ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...